All AbMole products are for research use only, cannot be used for human consumption.
QC6352 is a potent KDM4C inhibitor. QC6352 blocks proliferation and self-renewal of BCSCs.
In vivo, QC6352 strongly affects tumor growth and final tumor weight of both BCSC1 and BCSC2 xenografts. Treatment with QC6352 is well tolerated and does not affect body weight of the mice. Results demonstrate that treatment with the KDM4 inhibitor QC6352 blocks BCSC xenograft tumor growth.
Molecular Weight | 387.47 |
Formula | C24H25N3O2 |
CAS Number | 1851373-36-8 |
Solubility (25°C) | DMSO ≥ 15 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Metzger E, et al. Cancer Res. KDM4 Inhibition Targets Breast Cancer Stem-like Cells.
Related Histone demethylase Products |
---|
PFI-90
PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action. |
CPI-4203
CPI-4203 is a potent KDM5A inhibitor with an IC50 of 250 nM. |
KDM2B-IN-4
KDM2B-IN-4 is a histone demethylase KDM2B inhibitor. |
Zavondemstat
Zavondemstat (QC8222; TACH 101) is an inhibitor of histone lysine demethylase 4D (KDM4D) with antineoplastic activity. |
Zavondemstat L-lysine
Zavondemstat (QC8222; TACH 101) (L-lysine) is an inhibitor of histone lysine demethylase 4D (KDM4D) with antineoplastic activity. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.